Alamar Biosciences, Inc. (ALMR) vs Beam Therapeutics Inc. (BEAM)
A side-by-side comparison of Alamar Biosciences, Inc. and Beam Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMR
Alamar Biosciences, Inc.
$32.25HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
BEAM
Beam Therapeutics Inc.
$25.09HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — ALMR vs BEAM
growth of $100 · dividends reinvested · last 1yALMR +73.3% (+73.3%/yr)BEAM -18.2% (-18.2%/yr)ALMR compounded faster over this window
ALMR BEAM
ALMR vs BEAM: by the numbers
- •BEAM is the larger company ($2.58B vs $2.24B market cap).
- •Both run net losses; ALMR's is the smaller (-40.18% vs -54.75% net margin).
Metrics side by side
Valuation
| Metric | ALMR | BEAM |
|---|---|---|
| P/S ratio | N/A | 16.54 |
| P/B ratio | 7.14 | 2.42 |
Profitability
| Metric | ALMR | BEAM |
|---|---|---|
| Gross margin | 56.20% | 84.05% |
| Operating margin | -42.22% | -274.57% |
| Net margin | -40.18% | -54.75% |
| ROE | N/A | -8.00% |
| ROIC | -26.95% | -28.96% |
Growth (annualized)
| Metric | ALMR | BEAM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 479.04% |
| Total return CAGR (5Y) | N/A | -21.41% |
Go deeper
Dig into the metrics
Alamar Biosciences ROEBeam Therapeutics ROEAlamar Biosciences operating marginBeam Therapeutics operating marginAlamar Biosciences revenue growthBeam Therapeutics revenue growthAlamar Biosciences free cash flowBeam Therapeutics free cash flow
Alamar Biosciences & Beam Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.